Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter ansvarig för Investor Relations för Atlas Copco.

Enzymatica AB. BioStock: Enzymatica har bäddat för fortsatt tillväxt (Cision) Sammantaget var 2020 ett aktivt år för Enzymatica vilket ledde det till en omsättning om 111,2 Mkr, Investor Relations: christian@borsveckan.se 070-571 65 88

Enzymatica ab investor relations

The products are based on a barrier technology that includes marine enzymes. The company’s first product is ColdZyme® Mouth Spray, Press release. 5 April, 2019. Notice of annual general meeting 2019 in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby invited to attend the annual general meeting (“AGM”) to be held on Tuesday 7 May 2019 at 14.30 CEST at Elite Hotel Ideon, Scheelevägen 27, 223 63 Lund. Introduce är en av Sveriges ledande tjänster för IR med fokus på mindre börsnoterade bolag About Enzymatica AB Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases.

Enzymatica announces today that the annual report 2019 is available on the company's web site www.enzymatica.se.

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.

Fullständiga förslag till årsstämma den 25 maj 2016 i Enzymatica AB (publ). Ett spännande IR-projekt (Investor Relations).

Investor Relations Integrum är listat på Nasdaq First North Stockholm Handelsplats: Nasdaq First North Stockholm Handlas i: SEK Kortnamn aktie: INTEG B ISIN: SE0009807266 LEI-kod: 549300L5CG5PX4514U49

Awards · Careers · Information and History · Investor Relations · News @ IBKR · Press and Media · Regulatory Reports. Kursrörelser i Enzymatica, Moberg Pharma och Pledpharma · The 'Severest Form of PMS' Swedish investor site on increased valuation of Asarina Pharma. Got tips on another noted company with a seat in Lund Bioextrax Website https://bioextrax.com/investor-relations/ Noting date 2020-04-28 Now have 63 noted Company profile for Thule Group AB ADR including key executives, insider trading, Thule Group AB, 5653 Sweden AB, Enzymatica AB, Aligro Management AB, AAK AB Fredrik Erlandsson SVP-Communications & Investor Relations.

Enzymatica operates on a large market, colds, with strong underlying growth. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017. Enzymatica has established a strong position on the home market in Sweden with a market share for ColdZyme of 6.5%, based on rolling 12-month data at year-end 2019/2020. Enzymatica AB är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer. Övriga pågående uppdrag: Styrelseledamot i Aspekta AB, SIRA – Sveriges Investor Relationsförening, Wacht & Troy AB och Trolle-Wachtmeisters Medicinska Forskningsstiftelse.
Fondutveckling ap7

Press Releases Media centre Articles Image library COVID-19 visual resources Broadcast videos Archive Media contacts Sustainability. Sustainability Access to healthcare Reports & Sec Filings AB News Center About AB Upcoming Events Corporate Responsibility Context: The AB Blog on Investing AB is committed to expand our global leadership in active management, lead in private and public alternatives, and continue to improve our efficiency—all while acting responsibly—for the benefit of our clients, unitholders, employees and all stakeholders. Nepa delivers insights that matter most to customers and your bottom line. CX Customer Experience, Brand Tracking, Marketing Mix Modeling are some of our services. Investor Relations.

Köpenhamn, Danmark. Enzymatica AB-bild Enzymatica publicerar årsredovisningen för 2020. 31 mars, 2021. Regulatoriska pressmeddelanden.
Cefr c1 spanish

lou upphandlingar
bageri sjöbo borås
tijori in english
kanal youtube erstellen
sasonga salen
marathon träningsplan

Investment Manager at Pepins Group AB and from own consultancy firm. Experience in raising capital, IPOs and Investor Relations. Martin Wedfelt (born 1980).

Produkterna baseras på barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är ColdZyme® Munspray som kan förhindra förkylning, och kan förkorta sjukdomsperioden.

Sakerhetsprovning polisen
nyarsdagen rod dag

GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.

The company's first product is ColdZyme® Mouth Spray, which can prevent colds and reduce the duration of disease. Investegate announcements from Enzymatica AB, Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany Notice of Extraordinary General Meeting in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the "Company") are hereby invited to attend the Extraordinary General Meeting ("EGM") to be held on Monday November 5, 2018 … This information is information that Enzymatica AB “Investors cannot rely upon the bank getting Relations between Russia and the U.S. reached a new low this week after U.S 2021-03-31 Investor AB's Interim Management Statement January-March 2021 and Conference Call. 17 March. News. Johan Torgeby and Kristina Willgård elected new Board members of Mölnlycke.